Urica Therapeutics

uricatherapeutics.com
1111 Kane Concourse Suite 301
Miami, FL 33154

Company Info

Year Established
2019

Ticker
FBIO

Exchange
NASDAQ

Contacts

Jay D. Kranzler, M.D., Ph.D.
Chair & CEO

Company Description

Urica Therapeutics, formerly UR-1 Therapeutics, and a Fortress Biotech company, is focused on the development and commercialization of pharmaceutical products to treat gout and chronic kidney disease